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Dr Ralph Damiano (St. Louis, Mo). Dr Schaff, I congratulate
you and your coauthors on an important contribution. This is
a landmark report that will have a significant impact on the clinical
management of patients with symptomatic HCM.
The study stresses the importance of a team approach in the ma-
nagement of HCM and a careful preoperative echocardiographicThe Journal of Thoracic and Caexamination for provocable gradients in these patients. I have
several questions for you regarding this excellent contribution.
The first question is, what was the range of provocable gradi-
ents, particularly in the latent group? Were patients with higher
provocable gradients more likely to have late symptomatic
relief?
Dr Schaff. We don’t have information on the extent of the
provocable gradients other than being able to say it was more
than 50 mm Hg, and the reason is that once the patient achieved
that gradient with a Valsalva maneuver, cardiologists did not go
further with provocation with Isuprel or exercise that may have in-
creased with gradient further. The provoked gradient, then, is not
the maximum provoked gradient.
Dr Damiano. Did you find any preoperative or intraoperative
correlates with poor late functional outcome? Particularly when
you went back and looked at the patients who had recurrent heart
failure, were they the patients who had preoperative echocardio-
graphic criteria for diastolic dysfunction?
Dr Schaff.We don’t have any information on diastolic dysfunc-
tion, but it makes sense that patients with a larger left ventricular
mass have more diastolic dysfunction and might be more likely to
have late heart failure.
Dr Damiano. I was intrigued with the large number of patients
who underwent concomitant mitral valve surgery.Would you com-
ment on your techniques of mitral valve repair in these patients?
Did the presence of preoperative mitral regurgitation or residual
postoperative mitral regurgitation correlate with functional
improvement?
Dr Schaff. No. The mitral regurgitation for most patients with
dynamic outflow tract obstruction will be improved with myec-
tomy alone. Of approximately 10% of patients who had some-
thing done to the mitral valve, most had intrinsic degenerative
mitral valve disease as an associated problem. There were
a few who had injury to the mitral valve during myectomy. Our
approach is to first perform the myectomy, discontinue cardiopul-
monary bypass, and then reassess the valve once the obstruction is
relieved to see whether there is residual regurgitation. If mitral re-
gurgitation persists, we would resume extracorporeal circulation
and repair the valve. I think it is important to assess the valve
once the gradient is relieved before making a decision for valve
repair.
Dr Damiano. Thank you. Congratulations.rdiovascular Surgery c Volume 143, Number 2 309
